ERBB2 and breast cancer: In the present study, we demonstrated that for cytologic breast cancer samples, rapid‐CytoFISH with AC mixing can be used to detect HER2 amplification within the same day, enabling clinicians get both a cancer diagnosis and the HER2 result within 1 day.